IRS2
Insulin Receptor Substrate 2 (IRS2) is a key protein in the insulin signaling pathway, which plays a critical role in the body's metabolic and cellular growth processes. IRS2 is one of several Insulin Receptor Substrate proteins that mediate the effects of insulin and insulin-like growth factor (IGF) on various cellular functions. It is encoded by the IRS2 gene in humans.
Function
IRS2 is involved in transmitting signals from the insulin receptor and IGF receptors to the interior of the cell, influencing various physiological processes. Upon activation by insulin or IGF, IRS2 becomes phosphorylated on multiple tyrosine residues. This phosphorylation creates binding sites for various signaling proteins, leading to the activation of downstream pathways such as the PI3K/AKT signaling pathway, which is crucial for regulating glucose homeostasis, cell growth, and cell differentiation.
Clinical Significance
Alterations in IRS2 function or expression can have significant implications for human health. For example, impaired IRS2 signaling has been associated with the development of type 2 diabetes, as it can lead to insulin resistance, a condition where the body's cells become less responsive to insulin, leading to elevated blood glucose levels. Additionally, IRS2 dysregulation has been implicated in the pathogenesis of certain cancers, as its involvement in cell growth and survival pathways can contribute to tumor development and progression.
Research
Research on IRS2 has focused on understanding its role in metabolic diseases and cancer. Studies have shown that enhancing IRS2 activity or expression can improve insulin sensitivity and glucose homeostasis, suggesting potential therapeutic strategies for treating type 2 diabetes. In cancer research, efforts are directed towards understanding how IRS2-mediated signaling contributes to tumor growth and identifying ways to target these pathways for cancer therapy.
See Also
- Insulin signaling pathway
- Insulin resistance
- Type 2 diabetes
- PI3K/AKT signaling pathway
- Insulin Receptor Substrate
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD